Matches in SemOpenAlex for { <https://semopenalex.org/work/W1963782016> ?p ?o ?g. }
- W1963782016 endingPage "850" @default.
- W1963782016 startingPage "837" @default.
- W1963782016 abstract "Acetylcholinesterase inhibitors (AChEIs) are the most widely used symptomatic treatment for mild to severe Alzheimer’s disease (AD) patients, while N-methyl-d-aspartic acid (NMDA) receptor antagonist memantine is licensed for use in moderate to severe AD patients. In this article, the effect of these compounds on resting state eyes-closed electroencephalographic (EEG) rhythms in AD patients is reviewed to form a knowledge platform for the European Innovative Medicine Initiative project “PharmaCog” (IMI Grant Agreement No. 115009) aimed at developing innovative translational models for drug testing in AD. Indeed, quite similar EEG experiments and the same kind of spectral data analysis can be performed in animal models of AD and in elderly individuals with prodromal or manifest AD. Several studies have shown that AChEIs affect both resting state EEG rhythms and cognitive functions in AD patients. After few weeks of successful treatment, delta (0–3 Hz) or theta (4–7 Hz) rhythms decrease, dominant alpha rhythms (8–10 Hz) increase, and cognitive functions slightly improve. Beneficial effects of these rhythms and cognitive functions were also found in AD responders to the long-term successful treatment (i.e. 6–12 months). In contrast, only one study has explored the long-term effects of memantine on EEG rhythms in AD patients, showing reduced theta rhythms. The present review enlightens the expected effects of AChEIs on resting state EEG rhythms in AD patients as promising EEG markers for the development of translational protocols both within the PharmaCog project and for wider use." @default.
- W1963782016 created "2016-06-24" @default.
- W1963782016 creator A5005536123 @default.
- W1963782016 creator A5007675164 @default.
- W1963782016 creator A5024471384 @default.
- W1963782016 creator A5027357828 @default.
- W1963782016 creator A5035394476 @default.
- W1963782016 creator A5036090830 @default.
- W1963782016 creator A5038915894 @default.
- W1963782016 creator A5045793605 @default.
- W1963782016 creator A5057712173 @default.
- W1963782016 creator A5061357555 @default.
- W1963782016 creator A5062777125 @default.
- W1963782016 creator A5075604674 @default.
- W1963782016 creator A5079246880 @default.
- W1963782016 date "2013-05-01" @default.
- W1963782016 modified "2023-10-17" @default.
- W1963782016 title "Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer’s disease patients" @default.
- W1963782016 cites W119529559 @default.
- W1963782016 cites W1412088801 @default.
- W1963782016 cites W1498616187 @default.
- W1963782016 cites W1525243744 @default.
- W1963782016 cites W1596426405 @default.
- W1963782016 cites W1676571406 @default.
- W1963782016 cites W173790180 @default.
- W1963782016 cites W1760834562 @default.
- W1963782016 cites W1774702205 @default.
- W1963782016 cites W1847168837 @default.
- W1963782016 cites W1862942562 @default.
- W1963782016 cites W1953027527 @default.
- W1963782016 cites W1965749926 @default.
- W1963782016 cites W1968294251 @default.
- W1963782016 cites W1972300483 @default.
- W1963782016 cites W1974400337 @default.
- W1963782016 cites W1974494316 @default.
- W1963782016 cites W1975903968 @default.
- W1963782016 cites W1975963356 @default.
- W1963782016 cites W1976671772 @default.
- W1963782016 cites W1980806973 @default.
- W1963782016 cites W1981238903 @default.
- W1963782016 cites W1984753123 @default.
- W1963782016 cites W1984828228 @default.
- W1963782016 cites W1985228146 @default.
- W1963782016 cites W1985738518 @default.
- W1963782016 cites W1986471715 @default.
- W1963782016 cites W1992776590 @default.
- W1963782016 cites W1993055434 @default.
- W1963782016 cites W1994581892 @default.
- W1963782016 cites W1996776294 @default.
- W1963782016 cites W1998059774 @default.
- W1963782016 cites W2000406026 @default.
- W1963782016 cites W2000554818 @default.
- W1963782016 cites W2000837493 @default.
- W1963782016 cites W2001428189 @default.
- W1963782016 cites W2001888863 @default.
- W1963782016 cites W2002634186 @default.
- W1963782016 cites W2002815682 @default.
- W1963782016 cites W2004846239 @default.
- W1963782016 cites W2006001063 @default.
- W1963782016 cites W2006858320 @default.
- W1963782016 cites W2012785000 @default.
- W1963782016 cites W2014770695 @default.
- W1963782016 cites W2016375707 @default.
- W1963782016 cites W2019442762 @default.
- W1963782016 cites W2020350236 @default.
- W1963782016 cites W2021834808 @default.
- W1963782016 cites W2024214628 @default.
- W1963782016 cites W2025867113 @default.
- W1963782016 cites W2025969195 @default.
- W1963782016 cites W2029546674 @default.
- W1963782016 cites W2029854254 @default.
- W1963782016 cites W2029975586 @default.
- W1963782016 cites W2031477310 @default.
- W1963782016 cites W2031709382 @default.
- W1963782016 cites W2034211658 @default.
- W1963782016 cites W2036698216 @default.
- W1963782016 cites W2037420423 @default.
- W1963782016 cites W2038003677 @default.
- W1963782016 cites W2039523677 @default.
- W1963782016 cites W2039664444 @default.
- W1963782016 cites W2039739143 @default.
- W1963782016 cites W2040434160 @default.
- W1963782016 cites W2041110161 @default.
- W1963782016 cites W2042466531 @default.
- W1963782016 cites W2042698296 @default.
- W1963782016 cites W2042950178 @default.
- W1963782016 cites W2046557233 @default.
- W1963782016 cites W2047095305 @default.
- W1963782016 cites W2049445666 @default.
- W1963782016 cites W2051118933 @default.
- W1963782016 cites W2051176772 @default.
- W1963782016 cites W2051342416 @default.
- W1963782016 cites W2051782655 @default.
- W1963782016 cites W2052419306 @default.
- W1963782016 cites W2052471278 @default.
- W1963782016 cites W2052742260 @default.
- W1963782016 cites W2054105239 @default.
- W1963782016 cites W2054154241 @default.